These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28704273)

  • 21. Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand.
    Guo Y; Zhang H; Chen X; Cai W; Cheng J; Yang Y; Jin G; Zhen X
    Schizophr Res; 2009 Nov; 115(1):41-9. PubMed ID: 19744833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A primate model of schizophrenia using chronic PCP treatment.
    Mao CV; Hori E; Maior RS; Ono T; Nishijo H
    Rev Neurosci; 2008; 19(2-3):83-9. PubMed ID: 18751516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats.
    Savolainen K; Ihalainen J; Jalkanen AJ; Forsberg MM
    Psychopharmacology (Berl); 2019 Apr; 236(4):1245-1253. PubMed ID: 30535904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
    Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired social motivation and increased aggression in rats subchronically exposed to phencyclidine.
    Audet MC; Goulet S; Doré FY
    Physiol Behav; 2009 Mar; 96(3):394-8. PubMed ID: 19046980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats.
    Boulay D; Depoortère R; Louis C; Perrault G; Griebel G; Soubrié P
    Neuropharmacology; 2004 Jun; 46(8):1121-9. PubMed ID: 15111019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of phencyclidine (PCP) on anxiety-like behavior in the elevated plus maze and the light-dark exploration test are age dependent, sexually dimorphic, and task dependent.
    Turgeon SM; Kim D; Pritchard M; Salgado S; Thaler A
    Pharmacol Biochem Behav; 2011 Nov; 100(1):191-8. PubMed ID: 21889525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal handling prevents the effects of phencyclidine in an animal model of negative symptoms of schizophrenia.
    Tejedor-Real P; Sahagún M; Biguet NF; Mallet J
    Biol Psychiatry; 2007 Apr; 61(7):865-72. PubMed ID: 17125743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of acute amphetamine and phencyclidine treatment and withdrawal from repeated amphetamine or phencyclidine treatment on social interaction and social memory in rats.
    Li M; He W; Munro R
    Psych J; 2012 Jun; 1(1):56-68. PubMed ID: 26272667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia.
    Haller J; Szirmai M; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2005 Sep; 16(5-6):415-22. PubMed ID: 16148446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
    Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
    J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of withdrawal from repeated phencyclidine administration on behavioural function and brain arginine metabolism in rats.
    Knox LT; Jing Y; Bawazier-Edgecombe J; Collie ND; Zhang H; Liu P
    Pharmacol Biochem Behav; 2017 Feb; 153():45-59. PubMed ID: 27986516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats.
    Schwabe K; Klein S; Koch M
    Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity.
    Sams-Dodd F
    Rev Neurosci; 1999; 10(1):59-90. PubMed ID: 10356992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.
    Terranova JP; Chabot C; Barnouin MC; Perrault G; Depoortere R; Griebel G; Scatton B
    Psychopharmacology (Berl); 2005 Aug; 181(1):134-44. PubMed ID: 15830220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of subchronic phencyclidine on behaviour of female rats on the elevated plus maze and open field.
    McLean SL; Woolley ML; Neill JC
    J Psychopharmacol; 2010 May; 24(5):787-90. PubMed ID: 19264814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
    Bruins Slot LA; Kleven MS; Newman-Tancredi A
    Neuropharmacology; 2005 Dec; 49(7):996-1006. PubMed ID: 16009387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of subchronic phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field tests.
    Enkel T; Thomas M; Bartsch D
    Behav Brain Res; 2013 Apr; 243():61-5. PubMed ID: 23299039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.